Professional Documents
Culture Documents
No Drugs are
Dangerous if
used properly
Some drugs
have a low
therapeutic ratio
The most
dangerous drugs
have the greatest
potential for
benefit
Some adverse
effects occur
after a delay or
after stopping
BAD
GOOD
Some adverse
effects can be
predicted if you
know the
pharmacology
(Type A); some
are not (Type B)
BENEFIT
Is it effective ?
What are the chances of adverse effect ?
Are there features in this patient which
affect choice eg other drugs, organ failure,
aged
Tailoring the dose
Considering duration of treatment
AnADRisanyunwantedeffect
resultingfromadrugsusein
treatment.
Epidemiology
4%ofhospitaladmissions
1in1000deathsinmedicalwards
10to20%ofin-patients
5%ofpatientsingeneralpractice
Morefrequentinelderly:
erraticdrugtaking
multiplepathology
alteredpharmacokinetics
increasedsensitivityofCNS
andCVS
Drugs-anti-coagulants,
NSAIDs,corticosteroids,antihypertensives,anti-biotics,
diureticsandinsulin.
Occurincircumstancesrelatedto
drugspharmacology,
predisposingfactorsinthe
patientandcaretakenin
choosingthedrugandthedose.
TheBNFappendices
DrugInteractions
Liverdisease
Renalimpairment
Pregnancy
Breastfeeding
BNFchaptersofrelevance
Adversereactionstodrugs
Prescribingintheelderly
Prescribingforchildren
Emergencytreatmentofpoisoning
DetectingAdverseEffects
Ifanewdrugcausesabizarreeffectin1in6000
patientsitwouldneed18000patientstousethe
drugforittooccurin3patients
Itwouldtaketwiceasmanybeforetherewasany
suspicionthattheeffectwasduetothedrug
Iftheeffectalsooccursnaturallythenitwould
takemanytimesmorepatients
Mostearlytrialsinvolveabout2000patients
DetectingAdverseEffects
MRHA(MedicineandHealthcareproducts
RegulatoryAgency)freephoneservicefor
reportingandinformationaboutsuspected
ADRs
Selfreportingbypatientsandrelativesusing
Yellowcardsavailableatpharmacies
Prescriptioneventmonitoring
Newdrugsblacktrianglesandyellow
cards
Establisheddrugs
Measuringdanger
MHRAactivity
throughYellowcard
reportingand
prescription
monitoring
Hugeincrease
inreportsover
recentyears
WhoreportstotheMHRA?
Under-reporting estimated at 94% in hospital practice
(Smith et al 1996)
MRHA activity good at detecting adverse effects
Not very good at assessing the risk ratio
PreventionofAdverseDrug
reactions
Neveruseanydrugunlessthereisgood
indication.Ifthepatientispregnantdonot
usethedrugunlesstheneedisimperative.
Allergyandidiosyncrasyareimportant
causesofADRs.Askifthepatienthad
previousreactions.
Askifthepatientisalreadytakingother
drugsincludingselfmedication
PreventingADRscontd
Age,hepaticandrenaldiseasemayimpairclearance
ofdrugssosmallerdosesmaybeneeded.Genetic
factorsmayalsopredisposetocertainADRs
Prescribeasfewdrugsaspossibleandgiveclear
instructions
Wherepossibleusefamiliardrugs.Withnewdrugs
beparticularlyalertforADRsandunexpectedevent.
IfseriousADRsareliabletooccurwarnthepatient
Somewebsites
www.yellowcard.gov.uk
http://medicines.mhra.gov.uk
www.dsru.org
http://eis.bris.ac.uk/~pmcjcr/Drug%20Safety
.pdf